Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis

Background: Efficient personalized therapy paradigms are needed to modify the disease course and halt gray (GM) and white matter (WM) damage in patients with multiple sclerosis (MS). Presently, promising disease-modifying drugs show impressive efficiency, however, tailored markers of therapy respons...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Ciolac, Dumitru, Luessi, Felix, Gonzalez-Escamilla, Gabriel, Koirala, Nabin, Riedel, Christian, Fleischer, Vinzenz, Bittner, Stefan, Krämer, Julia, Meuth, Sven G., Muthuraman, Muthuraman, Groppa, Sergiu
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6682686/
https://ncbi.nlm.nih.gov/pubmed/31417557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01779
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires